• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Boston Scientific is selling a Minnesota campus

Boston Scientific is selling a Minnesota campus

June 10, 2025 By Chris Newmarker

This is a CBRE image of the Boston Scientific campus in Minnetonka, Minnesota.
The Boston Scientific campus in Minnetonka, Minnesota. [Image courtesy of CBRE]

Boston Scientific (NYSE: BSX) has put its 24-acre Minnetonka, Minnesota, campus up for sale as it continues to expand in Maple Grove — another Minneapolis suburb about 10 miles to the north.

The Minnesota Star Tribune first reported the news about the listing of the campus.

The CBRE listing notes that Boston Scientific has had a presence at 10700 Bren Road W. since the 1980s, with a redevelopment taking place in 2013. The campus comprises 225,900 ft² of finished lab, office, and warehouse space — and has primarily been used for medical device manufacturing over the years.. The site is near a planned station for the Minneapolis light rail system’s Metro Green Line Extension, which is slated to open in 2027.

In a statement shared by a spokesperson, the company told MassDevice that the jobs at the site are moving in the first half of 2026 to an expansion of the company’s Weaver Lake Road campus in Maple Grove, where construction is underway on an initial 52,000 ft² expansion. According to CCX Media, the project will eventually double the size of the campus’s facilities to 170,000 ft².

Said the company: “Across Boston Scientific we continuously align our real estate and workspace to support our business strategy as well as our growth.”

Meanwhile, a much larger 400,000 ft² Boston Scientific divisional headquarters campus is expected to open this year in Maple Grove at a site near Interstate 694 and U.S. 169.

The expansions come as Boston Scientific continues to enjoy the success of its cardiology products, including the Farapulse pulsed field ablation system for treating AFib and the Watchman LAA closure device. Company officials said in April that they didn’t expect ongoing U.S. trade wars to hinder another year of double-digit sales growth. They’re projecting 17% sales growth this year.

A Star Tribune article headline jested earlier his year that with 10,000 of its 53,000 employees at sites in Maple Grove and Arden Hills in the Minneapolis–St. Paul metro, Marlborough, Massachusetts–based Boston Scientific was becoming a “Minnesota Scientific.”

Filed Under: Business/Financial News, Featured Tagged With: Boston Scientific, Minnesota

More recent news

  • Siemens Healthineers exits general ultrasound to focus on cardiac imaging
  • Johnson & Johnson MedTech sets mid-2027 target for ortho spinoff, as Q3 device sales disappoint
  • Olympus receives FDA warning letter after international inspections
  • Stryker dives into soft-tissue robotics with $400M play for CMR Surgical’s Versius
  • Massachusetts Life Sciences Center offers grants to lower medtech commercial risk

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy